Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Key statistics for acute myeloid leukemia (AML)
with VIP (Vasoactive Intestinal Peptide), which has potent anti-inflammatory, neuroprotective, and immune-modulating effects
All protocols are accessed through guided, third-party research programs with clinician oversight
Industry analysts project a potential launch in 2028, though timelines could shift depending on regulatory review
US$ 27.70
US$ 28.30
US$ 29.45
US$ 25.90
US$ 20.30
US$ 23.69
US$ 24.79
US$ 24.95
US$ 22.05
